Dr. Nigg’s research focuses on the underlying mechanisms and causes in attention deficit hyperactivity disorder (ADHD) across the lifespan. The primary focus is on cognitive and neuropsychological mechanisms. However, studies of genetics, family dynamics, personality and temperament, environmental toxins, and neuroimaging of ADHD are also ongoing.
Joel Nigg
Director, Division of Psychology
Oregon Health and Science University
From this contributor
Insights for autism from attention deficit hyperactivity disorder
Autism and attention deficit hyperactivity disorder show genetic and neurobiological overlap, which may provide clues to the origin of both disorders, says Joel Nigg.
Insights for autism from attention deficit hyperactivity disorder
By
Joel Nigg
7 February 2012 | 8 min read
Explore more from The Transmitter
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
By
Amber Dance
18 September 2026 | 9 min read
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
By
Brendan Borrell
17 September 2026 | 4 min read
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
By
Brady Huggett
17 September 2026 | 1 min read